Pulmonary Hypertension, an Evolutional Disease with Multidisciplinary Team Management

Zhang, C., Huang, X., Li, S., Yao, H., & Zhang, B. (2016). Pulmonary Artery Dissection: A Fatal Complication of Pulmonary Hypertension. Case Reports in Medicine, 2016(), 342-346. https://doi.org/10.1155/2016/4739803
吳書豪、吳懿哲（2016）。Treatment Strategy and Response for Pulmonary Arterial Hypertension。台灣醫學，20(2)，167-176。https://doi.org/10.6320/FJM.2016.20(2).6
Hsu, C. H., Huang, W. C., & Chang, W. T. (2022). Future Perspectives of Pulmonary Hypertension Treatment. Acta Cardiologica Sinica, 38(4), 435-442. https://doi.org/10.6515/ACS.202207_38(4).20220331A
Wang, Y. C., Huang, W. C., Cheng, C. C., Hung, C. C., Kuo, F. Y., & Mar, G. Y. (2020). Managing Pulmonary Hypertension in Times of COVID-19. Acta Cardiologica Sinica, 36(4), 394-395. https://doi.org/10.6515/ACS.202007_36(4).20200619C
Wu, S. H., & Wu, Y. J. (2022). Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression. Acta Cardiologica Sinica, 38(2), 113-123. https://doi.org/10.6515/ACS.202203_38(2).20211005A